Alma Viso

Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosis

Silvia Ortega‐Gutiérrez, Eduardo Molina‐Holgado, Ángel Arévalo-Martı́n et al. · The FASEB Journal · 2005 · 121 citations

Immunology, Human Multiple Sclerosis, New Series +19

Comparison of Anandamide Transport in FAAH Wild-Type and Knockout Neurons:  Evidence for Contributions by both FAAH and the CB1 Receptor to Anandamide Uptake

Silvia Ortega‐Gutiérrez, Edward G. Hawkins, Alma Viso et al. · Biochemistry · 2004 · 90 citations

Design, Synthesis, and Biological Evaluation of New Inhibitors of the Endocannabinoid Uptake:  Comparison with Effects on Fatty Acid Amidohydrolase

María L. López-Rodrı́guez, Alma Viso, Silvia Ortega‐Gutiérrez et al. · Journal of Medicinal Chemistry · 2003 · 82 citations · Full text

Design, Synthesis and Biological Evaluation of Novel Arachidonic Acid Derivatives as Highly Potent and Selective Endocannabinoid Transporter Inhibitors

María L. López-Rodrı́guez, Alma Viso, Silvia Ortega‐Gutiérrez et al. · Journal of Medicinal Chemistry · 2001 · 69 citations · Full text

UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide

Eva de Lago, Javier Fernández‐Ruíz, Silvia Ortega‐Gutiérrez et al. · European Journal of Pharmacology · 2002 · 67 citations

Cannabis Use, Functional Selectivity, Medicine +8